Human Papillomavirus (HPV) Infection and Cervical Cancer

▴ Human Papillomavirus (HPV) Infection and Cervical Cancer
Viral infections lead to 15–20% of all human cancers. Despite effective screening methods, cervical cancer is a big public health problem. Cervical cancer incidence and mortality rates differ as per age and geographic region. Human papillomavirus (HPV) is a virus that can be sexually transmitted and is the cause of most cervical cancer specimens.

Human papillomavirus (HPV) is the most common viral infection of the reproductive tract. Sexually active women and men get infected by it at some or the other point in their lives. There can be repeated infections in some people. Cervical cancer is the 4th most common cancer that affects women globally. In 99.7% of cases, it is caused by Human papillomavirus (HPV). As per the review article published by Chan in Journal of Oncology, 90% of Human papillomavirus (HPV) infection become inactive within 12 to 24 months of exposure to the virus. There are close to 200 HPV types. Out of these about 40 types of HPV colonize in the genital tract. 

14 out of nearly 200 types of HPV are very high-risk cancer-causing types. They come in low and high-risk categories. Infections by the high-risk HPV types persist and increase the risk of cervical cancer. Type 16 and 18 are responsible for 70% of cervical cancer cases. HPV mostly gets transmitted right after the onset of sexual activity.

Cervical cancer symptoms

  • Light bleeding or irregular blood spotting between periods in reproductive-age females
  • Postmenopausal bleeding or spotting
  • Bleeding after intercourse
  • Foul-smelling increased vaginal discharge and discomfort
  • Persistent pelvis, back, or leg pain
  • Loss of appetite, weight loss
  • Swelling in legs

Cervical cancer treatment and cure

Human papillomavirus (HPV) is the most prevalent viral infection affecting the reproductive tract. Since it takes 15-20 years for cervical cancer to develop in women in general and 5-10 years to develop in women with low immune systems like people with HIV, precaution is better than cure.

  • All women should know that there are HPV vaccines that can be taken as a preventive measure. These vaccines are recommended by WHO and protect against HPV 16 and 18 which are cervical cancer-causing HPV types. 
  • Women generally tend to ignore pre-cancerous lesions in their cervical areas. Screening and treatment of such lesions are of high priority. Screening and treatment of precancerous lesions is a very cost-effective and extremely important way to prevent cervical cancer. 

The positive aspect is that cervical cancer can be cured if diagnosed at an early stage and treated effectively. Treatment options are surgery, radiotherapy, and chemotherapy depending upon the stage. There are enough palliative care options as well to manage cervical cancer so that unnecessary pain and suffering can be reduced as much as possible.

Tags : #humanpapillomavirus #cervicalcancer #HPV #cervicalcancersymptoms #cervicalcancertreatment #cervicalcancercure #cervicalcancercauses #smitakumar #medicircle

Related Stories

Loading Please wait...


Trending Now

Pervez Musharraf President of Pakistan died of Amyloidosis, a rare diseaseFebruary 07, 2023
National AIDS Control Program – Importance of knowing HIV statusFebruary 06, 2023
FGM : Let's End the practice that hurts girls and womenFebruary 06, 2023
World Cancer Day - Most prominent cancers of IndiaFebruary 04, 2023
World Cancer Day - Never Give up the HopeFebruary 04, 2023
Salt - Effects of Consuming too much SaltFebruary 03, 2023
India’s mission of eliminating dog-mediated rabies by 2030February 03, 2023
Climate change and healthFebruary 02, 2023
Rheumatoid Arthritis Awareness Day: Let's Create AwarenessFebruary 02, 2023
Importance of early diagnosis and cancer screeningFebruary 01, 2023
Union Budget 2023-2024: What's for Healthcare?February 01, 2023
Nourish You has raised $2million to Invest in R&D and Strengthen its Market Presence.February 01, 2023
Enzene Biosciences has raised $50million to expand in its core market of India and US.January 31, 2023
Enzene Biosciences has raised $50million to expand in its core market of India and US.January 31, 2023
World Leprosy Day 2023 – Act now, End LeprosyJanuary 30, 2023
The Warrior Expedition 32/26: A Mission to Encourage Youths to join Indian ForcesJanuary 30, 2023
Mental health – What’s normal and what’s abnormalJanuary 30, 2023
Big Data in Healthcare and Its BenefitsJanuary 27, 2023
Patient Advocacy - The voice of patientJanuary 27, 2023
Republic Day - Vision of Healthy IndiaJanuary 25, 2023